Innovative Research

CMS concentrates on innovative products that are global first-in-class or with the best efficacy, safety or cost-effectiveness in the class due to their innovative formulations or drug delivery systems. Through industrial investment in and/or establishment of joint venture with global innovative R&D companies and strategic cooperation with globally leading pharmas, the Group has established an innovative pipeline with relatively high innovation level, good market potential and competitive differentiation advantages.

Launched overseas /under marketing approval review

Product Indication Clinical Trial Approval Clinical Trial for Registration Marketing Approval Application Marketed Marketed Country/ Region

*Click the product name to enter the product detail page.

Under clinical stages

Product Indication Pre-IND Clinical Trial Approval Phase I Phase II Phase III Marketing Approval Application Marketed Country/ Region for Clinical Trials

*Click the product name to enter the product detail page.